Navigation Links
Stereotactic Breast Biopsy introduced with Fischer-Giotto Image at American Society of Breast Surgeons course
Date:5/1/2013

CHICAGO, IL (PRWEB) May 01, 2013

Fischer Medical Technologies will work with the educational arm of the American Society of Breast Surgeons (ASBS) by providing the use of the Fischer-Giotto Image for the introductory stereotactic breast biopsy workshop at the upcoming 14th annual ASBS conference. Fischer’s skilled technical staff from the U.S. and Italy will be assisting with the instruction.

The Fischer-Giotto Image is the only prone breast imaging system that uses the same detector during both the mammography exam and the biopsy procedure. This unique feature minimizes the need for additional exposures and dose, while providing superior quality images. The precise correlation of images produced by the dual-use detector provides more confidence, especially in vacuum assisted biopsies of subtle micro-calcifications.

The Fischer-Giotto Image, a FFDM (full-field digital mammography) and stereotactic breast biopsy system, was introduced in the U.S. in 2012. The first installation of the Fischer-Giotto Image was at Boulder Community Hospital, in Boulder, CO, replacing the Fischer Mammotest system. It is receiving enthusiastic reviews from both the physicians and technologists. Additional systems have been installed at Mankato Clinic (MN), Saratoga Hospital (NY) and Derby Family MedCenters (KS).

ASBS’s Stereotactic Breast Biopsy: An Introductory Course is a full-day session geared toward the breast surgeon with little or no prior experience in stereotactic breast biopsy. The course is currently filled to capacity, however, the Fischer-Giotto Image can be seen at the Fischer-Giotto Booth #203, at the ASBS conference, May 1-5, at the Sheraton Chicago Hotel & Towers.

ABOUT FISCHER MEDICAL TECHNOLOGIES
Fischer’s roots go back to 1910, when H.G. Fischer, the oldest manufacturer of X-ray imaging devices in the United States, began its operations in Chicago, IL. Fischer Medical Technologies LLC is based in Broomfield, Colorado and is the successor company to Fischer Imaging. Fischer Medical was formed in 2006 by the original founders of Fischer Imaging following the acquisition of all the assets of Fischer Imaging, including all patents, trademarks, product designs, and 510(k) filings. Fischer’s focus is on developing differentiated technologies to improve imaging systems’ efficiency and effectiveness through innovative and creative designs. Contact info@fischermti.com.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10680570.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Robert Lowen MD, Expert Bay Area Plastic Surgeon, Announces Cutting-Edge 3-D Crisalix Imaging Technology to Aid Patients in Choosing their Breast Implant Size
2. Patti Flint MD, A Top Female Plastic Surgeon in the Southwest, Is Proud To Offer Cutting-Edge 3D Crisalix Technology to Patients When Selecting Breast Implants
3. Dr. Vasquez at the Connecticut Plastic Surgery Group Now Offers the Unique Crisalix 3D Simulations for Facial Aesthetics and Breast Augmentation
4. QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research
5. The First Dedicated Breast Cancer Cell Line Transfection Reagent
6. NewLink Genetics Initiates Phase 2 Trial of IDO Pathway Inhibitor, Indoximod, for the Treatment of Metastatic Breast Cancer
7. University of Maryland Breast Cancer Research Pioneer Dr. Angela Brodie Appointed Fellow of New American Association for Cancer Research Academy
8. Genedata Enables Research to Improve Personalized Treatment of Breast and Ovarian Cancer
9. Positive Clinical Breast Cancer Data Presented for NuView’s Molecular Imaging Biomarker NLS-VPAC1
10. Frost & Sullivan: Modest Growth Projected in the U.S. Breast Imaging Systems Market Amidst Increasing Breast Cancer Prevalence
11. Transition in cell type parallels treatment response, disease progression in breast cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... 2017 , ... San Diego-based team building and cooking events company, Lajollacooks4u, has ... The bold new look is part of a transformation to increase awareness, appeal to ... period. , It will also expand its service offering from its signature gourmet cooking ...
(Date:10/10/2017)... 10, 2017 International research firm Parks Associates announced ... at the TMA 2017 Annual Meeting , October 11 in ... residential home security market and how smart safety and security products impact ... Parks Associates: Smart Home ... "The residential security market has ...
(Date:10/9/2017)... DIEGO , Oct. 9, 2017  BioTech ... biological mechanism by which its ProCell stem cell ... critical limb ischemia.  The Company, demonstrated that treatment ... amount of limbs saved as compared to standard ... the molecule HGF resulted in reduction of therapeutic ...
Breaking Biology Technology:
(Date:3/28/2017)... , March 28, 2017 The ... Hardware (Camera, Monitors, Servers, Storage Devices), Software (Video Analytics, ... Region - Global Forecast to 2022", published by MarketsandMarkets, ... 2016 and is projected to reach USD 75.64 Billion ... and 2022. The base year considered for the study ...
(Date:3/24/2017)... 24, 2017 The Controller General of Immigration from ... Abdulla Algeen have received the prestigious international IAIR Award for the ... Continue Reading ... ... Controller Abdulla Algeen (small picture on the right) have received the IAIR ...
(Date:3/23/2017)... The report "Gesture Recognition and Touchless Sensing Market by Technology (Touch-based ... to 2022", published by MarketsandMarkets, the market is expected to be worth USD ... 2022. Continue Reading ... ... ...
Breaking Biology News(10 mins):